(Q38292240)

1 September 2017

MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene (English)

1 reference

1 September 2017

1 reference

1 reference

4

1 reference

1 September 2017

Z Lu

1

1 reference

1 September 2017

M Liu

2

1 reference

1 September 2017

V Stribinskis

3

1 reference

1 September 2017

K S Ramos

5

1 reference

1 September 2017

N H Colburn

6

1 reference

1 September 2017

Y Li

7

1 reference

1 September 2017

language of work or name

English

0 references

publication date

31 March 2008

1 reference

1 September 2017

1 reference

1 September 2017

27

1 reference

1 September 2017

4373-4379

1 reference

1 September 2017

31

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2008.72

1 September 2017

0 references

cites work

Gene ontology: tool for the unification of biology

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

Real-time quantification of microRNAs by stem-loop RT-PCR

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

Alternative phospholipase D/mTOR survival signal in human breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

miRBase: microRNA sequences, targets and gene nomenclature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

MicroRNA gene expression deregulation in human breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

31 March 2020

Human MicroRNA targets

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

RAS is regulated by the let-7 microRNA family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

Combinatorial microRNA target predictions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

Why is PTEN an important tumor suppressor?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

Genome-scale loss-of-function screening with a lentiviral RNAi library

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

miR-21-mediated tumor growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

A microRNA expression signature of human solid tumors defines cancer gene targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.72

31 March 2020

Identifiers

DOI

10.1038/ONC.2008.72

1 reference

Dimensions Publication ID

1 September 2017

0 references

1 reference